ArticleInnate immunity2020

Select targeting of intracellular Toll-interleukin-1 receptor resistance domains for protection against influenza-induced disease.

Kari Ann Shirey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.